Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Rick, Admiraal"'
Autor:
Eva Koopman-Coenen, Joyce Meesters-Ensing, Stefan Nierkens, Ireen Kal, Konradin Müskens, Birgitta Versluys, Caroline Lindemans, Marc Bierings, Rick Admiraal, Mirjam Belderbos
Publikováno v:
EJC Paediatric Oncology, Vol 2, Iss , Pp 100033- (2023)
Externí odkaz:
https://doaj.org/article/8b2759f31c4642d7b8faf8dd648fa12d
Publikováno v:
Frontiers in Pediatrics, Vol 9 (2022)
Serotherapy comprising agents such as anti-thymocyte globulin, anti-T-lymphocyte globulin, and the anti-CD52 monoclonal antibody alemtuzumab is used widely to reduce the incidence of graft-versus-host disease (GvHD) after paediatric haematopoietic st
Externí odkaz:
https://doaj.org/article/73c91251a9634233bfad456e42e5f0db
Autor:
Coco de Koning, Julie-Anne Gabelich, Jurgen Langenhorst, Rick Admiraal, Jurgen Kuball, Jaap Jan Boelens, Stefan Nierkens
Publikováno v:
Blood Advances, Vol 2, Iss 5, Pp 565-574 (2018)
Abstract: Residual antithymocyte globulin (ATG; Thymoglobulin) exposure after allogeneic hematopoietic (stem) cell transplantation (HCT) delays CD4+ T-cell immune reconstitution (CD4+ IR), subsequently increasing morbidity and mortality. This effect
Externí odkaz:
https://doaj.org/article/39414988be6f4fef8073cbd663270820
Publikováno v:
Blood Advances, Vol 2, Iss 4, Pp 428-432 (2018)
Abstract: Human herpesvirus 6 (HHV6) viremia is a common cause of morbidity following allogeneic hematopoietic cell transplantation (HCT). We previously associated T-cell reconstitution with HHV6 viremia. Here, we investigated whether HHV6 viremia af
Externí odkaz:
https://doaj.org/article/c7f404a64b014e23a5147da9fa31732d
Autor:
Linde Dekker, Friso G. Calkoen, Yilin Jiang, Hilly Blok, Saskia R. Veldkamp, Coco De Koning, Maike Spoon, Rick Admiraal, Peter Hoogerbrugge, Britta Vormoor, H. Josef Vormoor, Henk Visscher, Marc Bierings, Marieke Van Der Vlugt, Harm Van Tinteren, A. Laura Nijstad, Alwin D. R. Huitema, Kim C. M. Van Der Elst, Rob Pieters, Caroline A. Lindemans, Stefan Nierkens
Publikováno v:
Blood Advances. 6:1969-1976
The addition of fludarabine to cyclophosphamide as a lymphodepleting regimen prior to CD19 chimeric antigen receptor (CAR) T-cell therapy significantly improved outcomes in patients with relapsed/refractory (r/r) B-cell acute lymphoblastic leukemia (
Autor:
Rick, Admiraal, Stefan, Nierkens, Marc B, Bierings, Robbert G M, Bredius, Ineke, van Vliet, Yilin, Jiang, Marta, Lopez-Yurda, A Birgitta, Versluijs, C Michel, Zwaan, Caroline A, Lindemans, Jaap Jan, Boelens
Publikováno v:
The Lancet Haematology, 9(2), e111-e120. Lancet Publishing Group
Background: Anti-thymocyte globulin, which is used in the conditioning of haematopoietic stem-cell transplantation (HSCT) to prevent graft-versus-host disease (GVHD) and graft failure, has highly variable pharmacokinetics. Overexposure to anti-thymoc
Autor:
Gunjan L. Shah, Jaap Jan Boelens, Rick Admiraal, Michael Scordo, Ryan Schofield, Andrew Lin, Roni Tamari, Anthony J. Proli, Sergio Giralt, Nancy Cruz Sitner, Anna Alperovich, Josel D. Ruiz, Dean Carlow, Parastoo B. Dahi
Publikováno v:
Clin Pharmacokinet
BACKGROUND AND OBJECTIVES High-dose melphalan is an integral part of conditioning chemotherapy prior to both autologous and allogeneic hematopoietic cell transplantation. While underexposure may lead to relapse, overexposure may lead to toxicities in
Publikováno v:
Cell and Gene Therapy Insights. 5:1495-1503
Autor:
Parastoo B. Dahi, Andrew Lin, Michael Scordo, Jessica R. Flynn, Sean M. Devlin, Josel D. Ruiz, Lauren DeRespiris, Dean Carlow, Christina Cho, Oscar B. Lahoud, Miguel-Angel Perales, Craig S. Sauter, Jan Jaap Boelens, Rick Admiraal, Sergio A. Giralt, Gunjan L. Shah
Publikováno v:
Transplantation and Cellular Therapy. 28:485.e1-485.e6
High-dose melphalan is one of the main cytotoxic DNA alkylating agents and is used in many transplantation conditioning regimens. Studies have shown a wide range of drug exposure when a traditional weight-based dose of melphalan is used. The optimal
Autor:
Linde Dekker, Friso Calkoen, Yilin Jiang, Hilly Blok, Maike Spoon, Rick Admiraal, Peter Hoogerbrugge, Britta Vormoor, Josef Vormoor, C. Michel Zwaan, Henk Visscher, Marc Bierings, Marieke Van Der Vlugt, Harm Van Tinteren, A. Laura Nijstad, Alwin D.R. Huitema, Kim Van Der Elst, Rob Pieters, Caroline A. Lindemans, Stefan Nierkens
Publikováno v:
Transplantation and Cellular Therapy. 28:S104-S105